İmmunsupresyon Tedavisi Alan Karaciğer Nakli Hastalarında Yaşam Kalitesi İle Algılanan Stres Arasındaki İlişkinin Değerlendirilmesi

Abstract

Amaç: Bu çalışma immunsupresyon tedavisi alan karaciğer nakli hastalarında yaşam kalitesi ile algılanan stres arasındaki ilişkinin değerlendirilmesi amacıyla yapılmıştır. Materyal ve Metot: Bu çalışma, bir üniversite hastanesinin karaciğer nakli merkezinde yatan 124 karaciğer nakli hastasının katılımıyla gerçekleştirilmiş kesitsel bir çalışmadır. Bulgular: Katılımcıların algılanan stres ölçeği (ASÖ) ile SF-36 Yaşam Kalitesi Ölçeği (SF-36) alt ölçekleri arasındaki korelasyon analizi sonucu; fiziksel fonksiyon, fiziksel rol güçlüğü, emosyonel rol güçlüğü, enerji/canlılık/vitalite, sosyal işlevsellik, genel sağlık algısı, ağrı alt boyutları arasında negatif yönde, zayıf düzeyde anlamlı bir ilişki bulunmuştur (r=-0,209 ile -0,480). ASÖ ile ruhsal sağlık alt boyutu arasında ise negatif yönde, orta düzeyde ve anlamlı bir ilişki saptanmıştır (r=-0,563). Yapılan regresyon analizi sonucunda ASÖ toplam puan ortalamasının SF-36 alt boyutlarına etkisi bakılmış ve %31,7 oranı ile en fazla ve negatif yönlü olarak ruhsal sağlık alt boyutu üzerine etkisinin olduğu bulunmuştur (R2=0,317; B= -0,962; p<0,001). Sonuç: Çalışma sonucu, karaciğer transplantasyonu sonrası erken dönemde hastaların yaşam kalitesinin ciddi düzeyde düşük olduğunu ve stresin yaşam kalitesini olumsuz yönde etkilediğini ortaya koymuştur.

Keywords

• İmmünsüpresif tedavi
• karaciğer nakli
• yaşam kalitesi
• stres

Determining the Relationship Between Quality of Life and Perceived Stress in Liver Transplant Patients Receiving Immunosuppression Therapy

Abstract

Objective: This study was conducted to evaluate the relationship between quality of life and perceived stress in liver transplant patients receiving immunosuppression therapy. Materials and Methods: This study is a cross-sectional study with the participation of 124 liver transplant patients hospitalized in the liver transplantation center of a university hospital. Results: The results of the correlation analysis between the perceived stress scale (PSS) and the 36-item Short Form Health Survey (SF-36) subscales of the participants: A negative and weak significant relationship was found between physical function, physical role difficulty, emotional role difficulty, energy/vitality, social functioning, general health perception, and pain sub-dimensions (r=-0.209 and -0.480). A negative, moderate and significant relationship was found between PSS and the mental health sub-dimension (r=-0.563). As a result of the regression analysis, the effect of the PSS total score average on SF-36 sub-dimensions was examined, and it was found that it had the highest and negative effect on the mental health sub-dimension with a rate of 31.7% (R2=.317; B=-1.962; p<0.001). Conclusions: Our study results revealed that patients' quality of life was low level in the early period after liver transplantation and that stress negatively affected their quality of life.

Keywords

• Immunosuppressive therapy
• liver transplantation
• quality of life
• stress

References

1. Becchetti C, Dirchwolf M, Banz V, Dufour JF. Medical management of metabolic and cardiovascular complications after liver transplantation. World J Gastroenterol. 2020;26(18):2138–54. doi:10.3748/wjg.v26.i18.2138
2. Cajanding R. Immunosuppression following organ transplantation. Part 1: Mechanisms and immunosuppressive agents. Br J Nurs. 2018;27(16):920–7. doi:10.12968/bjon.2018.27.16.920
3. Girgenti R, Tropea A, Buttafarro MA, Ragusa R, Ammirata M. Quality of life in liver transplant recipients: A retrospective study. Int J Environ Res Public Health. 2020;17(11):1–10.
4. Onghena L, Develtere W, Poppe C, et al. Quality of life after liver transplantation: State of the art. World J Hepatol. 2016;8(18):749–56. doi:10.3390/ijerph17113809
5. Demir B, Bulbuloglu S. The effect of immunosuppression therapy on activities of daily living and comfort level after liver transplantation. Transpl Immunol. 2021;69:101468. doi:10.1016/j.trim.2021.101468
6. Varo Pérez E, Castroagudín JF. The future of liver transplantation. Transplant Proc. 2010;42(2):613–6. doi: 10.1016/j.transproceed.2010.02.003
7. Burra P, Ferrarese A, Feltrin G. Quality of life and adherence in liver transplant recipients. Minerva Gastroenterol Dietol. 2018;64(2):180–6. doi:10.23736/S1121-421X.17.02459-X
8. Duffy JP, Kao K, Ko CY, et al. Long-Term Patient Outcome and Quality of Life After Liver. 2010;252(4):652-61.doi:10.1097/SLA.0b013e3181f5f23a

9. Ohnemus D, Neighbors K, Rychlik K, et al. Health-related quality of life and cognitive functioning in pediatric liver transplant recipients. Liver Transpl. 2020;26(1):45-56. doi:10.1002/lt.25634
10. Burra P, Ferrarese A. Health-related quality of life in liver transplantation: another step forward. Transpl Int. 2019;32(8):792–3. doi:10.1111/tri.13435
11. Åberg F. Quality of life after liver transplantation. Best Pract Res Clin Gastroenterol. 2020;46–47:101684. doi:10.1016/j.bpg.2020.101684
12. Sen A, Callisen H, Libricz S, Patel B. Complications of Solid Organ Transplantation: Cardiovascular, Neurologic, Renal, and Gastrointestinal. Crit Care Clin. 2019;35(1):169–86. doi:10.1016/j.ccc.2018.08.011
13. Hampson FA, Freeman SJ, Ertner J, et al. Pancreatic transplantation: surgical technique, normal radiological appearances and complications. Insights Imaging. 2010;1(5–6):339. doi:10.1007/s13244-010-0046-3
14. Bulbuloglu S, Kapikiran G. The effect of immunosuppressive therapy after liver transplantation on activities of daily living and fear of death during the COVID-19 pandemic. Transpl Immunol. 2021;69:101470. doi:10.1016/j.trim.2021.101470
15. Dougan C, Ormerod I. A neurologist’s approach to the immunosuppressed patient. J Neurol Neurosurg Psychiatry. 2004;75(Suppl 1):i43. doi:10.1136/jnnp.2003.035071
16. Kacmaz N, Barlas GU. The Psychsocial Status Of Liver Transplant Patient And Their Relatives On The Effect Of Quality Of Life. J Psychiatr Nurs. 2014;5(1):1–8. doi:10.5505/phd.2014.98598
17. Kinnunen S, Karhapää P, Juutilainen A, Finne P, Helanterä I. Article Secular Trends in Infection-Related Mortality after Kidney Transplantation. Clin J Am Soc Nephrol. 2018;13:755–62. doi:10.2215/CJN.11511017
18. Romero FA, Razonable RR. Infections in liver transplant recipients. World J Hepatol. 2011;3(4):83–92. doi:10.4254/wjh.v3.i4.83
19. Geissler EK. Post-transplantation malignancies: here today, gone tomorrow? Nat Rev Clin Oncol. 2015;12(12):705–17. doi:10.1038/nrclinonc.2015.186
20. Duncan S, Annunziato RA, Dunphy C, LaPointe Rudow D, Shneider BL, Shemesh E. A systematic review of immunosuppressant adherence interventions in transplant recipients: Decoding the streetlight effect. Pediatr Transplant. 2018. doi:10.1111/petr.13086
21. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol. 2006;5(2):77–85. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF 36). Med Care. 1992;30:473–483.
22. Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF 36). Med Care. 1992;30:473–483.
23. Pınar R. Sağlık araştırmalarında yeni bir kavram: yaşam kalitesi - bir yaşam kalitesi ölçeğinin kronik hastalarda geçerlik ve güvenirliğinin incelenmesi. Florence Nightingale Hemşirelik Dergisi. 1995;9:85–95.
24. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24(4):385–396.
25. Eskin M; Harlak H; Demirkıran F; Dereboy Ç. Algılanan stres ölçeğinin türkçeye uyarlanması: güvenirlik ve geçerlik analizi. Yeni Symp. 2013;51(3):132–140.
26. Wilhelm MJ. Long-term outcome following heart transplantation: Current perspective. J Thorac Dis. 2015;7(3):549–51. doi:10.3978/j.issn.2072-1439.2015.01.46
27. Global report on organ donation and transplantation 2020. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.transplant-observatory.org/wp-content/uploads/2022/07/2020-Global-report-para-web.pdf. Accessed December 3, 2022.
28. Santos R, Miyazaki MCOS, Domingos NAM, Valério NI, Silva RF, Silva RCMA. Patients undergoing liver transplantation: psychosocial characteristics, depressive symptoms, and quality of life. Transplant Proc. 2008;40(3):802–4. doi:10.1016/j.transproceed.2008.02.059
29. Mclean KA, Drake TM, Sgr A, Camilleri-Brennan J, Knight SR, Ots R, et al. The effect of liver transplantation on patient-centred outcomes: a propensity-score matched analysis. Transpl Int. 2019;32(8):808-819. doi:10.1111/tri.13416
30. Chen PX, Yan LN, Wang WT. Health-related quality of life of 256 recipients after liver transplantation. World J Gastroenterol. 2012;18(36):5114–21. doi:10.3748/wjg.v18.i36.5114